These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

850 related items for PubMed ID: 16806661

  • 1. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A, Burkhardt M, Jung M, Fritzsche F, Ringsdorf M, Schicktanz H, Loening SA, Kristiansen G, Jung K.
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [Abstract] [Full Text] [Related]

  • 2. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M, Hayasaka S, Taylor JM, Shah R, Proverbs-Singh T, Manley S, Rubin MA.
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [Abstract] [Full Text] [Related]

  • 3. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
    Rosner IL, Ravindranath L, Furusato B, Chen Y, Gao C, Cullen J, Sesterhenn IA, McLeod DG, Srivastava S, Petrovics G.
    Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
    [Abstract] [Full Text] [Related]

  • 4. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [Abstract] [Full Text] [Related]

  • 5. Re: Anja Rabien, Mick Burkhardt, Monika Jung, Florian Fritzsche, Martin Ringsdorf, Hanka Schicktanz, Stefan A. Loening, Glen Kristiansen and Klaus Jung. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy. Eur Urol 2007;51:1259-66.
    Shukla CJ, Edwards D, Sethia KK.
    Eur Urol; 2007 Nov; 52(5):1533-4; author reply 1534-5. PubMed ID: 17583418
    [No Abstract] [Full Text] [Related]

  • 6. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F.
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [Abstract] [Full Text] [Related]

  • 7. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L.
    Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720
    [Abstract] [Full Text] [Related]

  • 8. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.
    Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, Timme TL, Baba S, Thompson TC.
    Cancer; 2003 Mar 01; 97(5):1225-33. PubMed ID: 12599229
    [Abstract] [Full Text] [Related]

  • 9. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
    Khatami A, Hugosson J, Wang W, Damber JE.
    Scand J Urol Nephrol; 2009 Mar 01; 43(1):12-8. PubMed ID: 18949633
    [Abstract] [Full Text] [Related]

  • 10. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN, Roemeling S, Kranse R, Schröder FH, van der Kwast TH.
    Eur Urol; 2007 Apr 01; 51(4):931-9. PubMed ID: 16935413
    [Abstract] [Full Text] [Related]

  • 11. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer.
    Vis AN, Schröder FH, van der Kwast TH.
    Eur Urol; 2006 Aug 01; 50(2):258-65. PubMed ID: 16413660
    [Abstract] [Full Text] [Related]

  • 12. ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
    Fritzsche FR, Jung M, Tölle A, Wild P, Hartmann A, Wassermann K, Rabien A, Lein M, Dietel M, Pilarsky C, Calvano D, Grützmann R, Jung K, Kristiansen G.
    Eur Urol; 2008 Nov 01; 54(5):1097-106. PubMed ID: 18061337
    [Abstract] [Full Text] [Related]

  • 13. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z, Wenlu S.
    Prostate; 2007 May 01; 67(6):653-60. PubMed ID: 17342746
    [Abstract] [Full Text] [Related]

  • 14. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z, Liu J, Li S, Shen W.
    Prostate; 2009 Sep 01; 69(12):1292-302. PubMed ID: 19462463
    [Abstract] [Full Text] [Related]

  • 15. Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy.
    Xu C, Jung M, Burkhardt M, Stephan C, Schnorr D, Loening S, Jung K, Dietel M, Kristiansen G.
    Prostate; 2005 Feb 15; 62(3):224-32. PubMed ID: 15389793
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy.
    Reeves JR, Dulude H, Panchal C, Daigneault L, Ramnani DM.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6018-22. PubMed ID: 17062675
    [Abstract] [Full Text] [Related]

  • 17. PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer.
    Imasato Y, Xuan JW, Sakai H, Izawa JI, Saito Y, Chin JL, Moussa M.
    J Urol; 2000 Nov 15; 164(5):1819-24. PubMed ID: 11025776
    [Abstract] [Full Text] [Related]

  • 18. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM, Koch MO, Eble JN, Lin H, Cheng L.
    J Urol; 2006 May 15; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.
    Quinn DI, Henshall SM, Head DR, Golovsky D, Wilson JD, Brenner PC, Turner JJ, Delprado W, Finlayson JF, Stricker PD, Grygiel JJ, Sutherland RL.
    Cancer Res; 2000 Mar 15; 60(6):1585-94. PubMed ID: 10749127
    [Abstract] [Full Text] [Related]

  • 20. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
    Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, Wheeler TM, Ayala G, Thompson TC, Kadmon D.
    Clin Cancer Res; 2006 Aug 15; 12(16):4872-5. PubMed ID: 16914574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.